Bought
Maintained
Sold
Other funds holding CME
Nuveen's CME Position: Q3 2026 in Review
Nuveen reduced its CME Group (CME) stake by 0.28% in Q3 2026, selling an estimated $672K and leaving 923,433 shares worth $242M. The position accounts for 0.06% of the portfolio, ranked #237.
Nuveen first reported a position in CME in Q2 2013 and has held it in 54 quarters since. The position peaked at $663M in Q3 2019. 1,099 funds tracked by Wall St. Rank hold CME as of Q3 2026.
- Nuveen held 923,433 shares of CME Group worth $242M as of Q3 2026.
- Nuveen sold 2,549 CME Group shares in Q3 2026, an estimated $672K.
- CME Group made up 0.06% of Nuveen's portfolio in Q3 2026, its #237 holding.
- Nuveen first reported a position in CME Group in Q2 2013 and has held it in 54 quarters since.
- Nuveen's CME Group position peaked at $663M in Q3 2019.
- 1,099 funds tracked by Wall St. Rank held CME Group as of Q3 2026.
Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.